This therapy has resulted very effective against hematopoietic cancers, whereas it has not been very efficient against solid tumors, as CAR T cells become exhausted just like endogenous CD8 T cells responding to chronic infection or cancer [8,188]. This evidence concerns the gene CD8A and cancer.